Hôpital Intercommunal de Créteil (CHIC)
Hospital
Location:
Créteil,
France (FR)
ISNI: 0000000417652136
ROR: https://ror.org/04n1nkp35
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R (2024)
Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, et al.
Journal article
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022)
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al.
Journal article
PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021)
Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al.
Conference contribution